At the end of May, in a brand new virtual format, the annual meeting for the American Society of Clinical Oncology (ASCO) was one of the first such meetings to take place since COVID-19 caused disruptions and cancellations across the board. Scientific meetings such as this one are an important venue where scientists and researchers…
A phase 2 immunotherapy clinical trial combining durvalumab, an immunotherapy drug, with standard treatment of Alimta (pemetrexed)/cisplatin has shown promising overall survival results. The study enrolled 55 patients and showed a median survival of 20.1 months. Of those 55 patients, 31 demonstrated a partial response, and 22 had stable disease. Most frequently observed adverse events included fatigue, nausea, anemia, and constipation…
Each year, the American Society of Clinical Oncology unites oncologists from all over the country at the organization’s annual meeting. This year, we spoke with leading oncologist Dr. Nicholas Vogelzang and his son, our Lead Counsel Nicholas Vogelzang, about this year’s theme: Caring for every patient; learning from every patient. As a law firm that…
Fill Out the Form To Receive Yours In The Mail
The safety of our potential clients is a very high priority for us, so we aren’t meeting anyone in-person currently.
If you have a potential case, we will send you out an iPad with all the digital paperwork and we will communicate with you through that iPad. There are also no court appearances required.